| ²é¿´: 327 | »Ø¸´: 5 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| ¡¾Óн±½»Á÷¡¿»ý¼«»Ø¸´±¾Ìû×Ó£¬²ÎÓë½»Á÷£¬¾ÍÓлú»á·ÖµÃ×÷Õß ß÷ß÷9761 µÄ 7 ¸ö½ð±Ò £¬»ØÌû¾ÍÁ¢¼´»ñµÃ 1 ¸ö½ð±Ò£¬Ã¿ÈËÓÐ 1 ´Î»ú»á | |||
ß÷ß÷9761ͳæ (³õÈëÎÄ̳)
|
[½»Á÷]
¡¾ÇóÖú¡¿¼±ÇóһƪӢÎÄÎÄÏ×
|
||
|
±¾ÈËÖ»ÓÐÎÄÕÂÃû³Æ°¡£¬ÊµÔÚÕÒ²»µ½È«ÎÄ£¬ÄÜÕÒµ½µÄ³æ³æÃǰïæ°¡£¡Ð»Ð» Liversidge EM. Nanocrystals: resolving pharmaceutical formulation issues associated with poorly water-soluble compounds in: J.J. Marty (Ed.), Particles, Marcel Dekker, Orlando, 2002. |
» ²ÂÄãϲ»¶
294·Ö080500²ÄÁÏ¿ÆÑ§Ó빤³ÌÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
296Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
275Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
¡¾Çóµ÷¼Á¡¿085601²ÄÁϹ¤³Ìר˶ | ×Ü·Ö272 |
ÒѾÓÐ7È˻ظ´
²ÄÁÏÓ뻯¹¤272Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
283Çóµ÷¼Á£¨080500£©
ÒѾÓÐ6È˻ظ´
»¯Ñ§0703 µ÷¼Á 306·Ö Ò»Ö¾Ô¸211
ÒѾÓÐ7È˻ظ´
ÄϾ©´óѧ»¯Ñ§µ÷¼Á
ÒѾÓÐ10È˻ظ´
µ÷¼Á310
ÒѾÓÐ13È˻ظ´
²ÄÁÏר˶µ÷¼Á
ÒѾÓÐ4È˻ظ´
ß÷ß÷9761
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 192.3
- ºì»¨: 1
- Ìû×Ó: 36
- ÔÚÏß: 5Сʱ
- ³æºÅ: 588244
- ×¢²á: 2008-08-22
- רҵ: Ò©¼Áѧ
2Â¥2010-03-02 13:12:12
amisking:ÑϽû·¢´¿±íÇéÌù¡£ 2010-03-02 22:07
![]() |
3Â¥2010-03-02 13:13:03
ß÷ß÷9761
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 192.3
- ºì»¨: 1
- Ìû×Ó: 36
- ÔÚÏß: 5Сʱ
- ³æºÅ: 588244
- ×¢²á: 2008-08-22
- רҵ: Ò©¼Áѧ
4Â¥2010-03-03 21:14:17
ß÷ß÷9761
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 192.3
- ºì»¨: 1
- Ìû×Ó: 36
- ÔÚÏß: 5Сʱ
- ³æºÅ: 588244
- ×¢²á: 2008-08-22
- רҵ: Ò©¼Áѧ
5Â¥2010-03-03 21:27:45
ß÷ß÷9761
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 192.3
- ºì»¨: 1
- Ìû×Ó: 36
- ÔÚÏß: 5Сʱ
- ³æºÅ: 588244
- ×¢²á: 2008-08-22
- רҵ: Ò©¼Áѧ
6Â¥2010-03-03 21:28:27














»Ø¸´´ËÂ¥